Suzanne Sawochka Hooper

2016

In 2016, Suzanne Sawochka Hooper earned a total compensation of $2.8M as Executive Vice President and GC at Jazz Pharmaceuticals, a 12% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$300,000
Option Awards$902,696
Salary$521,154
Stock Awards$1,110,239
Other$5,622
Total$2,839,711

Hooper received $1.1M in stock awards, accounting for 39% of the total pay in 2016.

Hooper also received $300K in non-equity incentive plan, $902.7K in option awards, $521.2K in salary and $5.6K in other compensation.

Rankings

In 2016, Suzanne Sawochka Hooper's compensation ranked 3,410th out of 14,075 executives tracked by ExecPay. In other words, Hooper earned more than 75.8% of executives.

ClassificationRankingPercentile
All
3,410
out of 14,075
76th
Division
Manufacturing
1,187
out of 5,486
78th
Major group
Chemicals And Allied Products
359
out of 1,900
81st
Industry group
Drugs
260
out of 1,543
83rd
Industry
Pharmaceutical Preparations
204
out of 1,173
83rd
Source: SEC filing on June 20, 2017.

Hooper's colleagues

We found five more compensation records of executives who worked with Suzanne Sawochka Hooper at Jazz Pharmaceuticals in 2016.

2016

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2016

Russell Cox

Jazz Pharmaceuticals

Chief Operating Officer

2016

Matthew Young

Jazz Pharmaceuticals

Chief Financial Officer

2016

Karen Smith

Jazz Pharmaceuticals

Chief Marketing Officer

2016

Michael Miller

Jazz Pharmaceuticals

Executive Vice President U.S Commercial

News

You may also like